Beat Childhood Cancer Foundation Inc
We will beat childhood cancer.
Beat Childhood Cancer Foundation Inc
EIN: 27-2314549
as of September 2024
as of September 09, 2024
Programs and results
Reports and documents
Download annual reportsWhat we aim to solve
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
Clinical Research
We are committed to knowing the childhood cancer research landscape and specifically funding patient-affecting trials and research. We partner specifically with researchers, physicians, and scientists who fit our goal of making a difference in survival today. We work specifically with doctors and teams who are directly dealing with patient-affecting treatment options for solid-mass childhood cancer.
Where we work
Affiliations & memberships
CAC2 Member 2024
Photos
Videos
Our results
How does this organization measure their results? It's a hard question but an important one.
Total dollar amount of grants awarded
This metric is no longer tracked.Totals By Year
Population(s) Served
Children and youth
Related Program
Clinical Research
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Our Sustainable Development Goals
Learn more about Sustainable Development Goals.
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
Funding research and clinical trials for children with solid tumor cancers creating options for kids today to increase survival and decrease toxicity.
What are the organization's key strategies for making this happen?
We are committed to knowing the solid tumor research landscape and specifically funding patient-affecting trials and research. We partner specifically with researchers, physicians, and scientists who fit our goal of making a difference in survival today. We work specifically with doctors and teams who are directly dealing with patient-affecting treatment options for solid-mass childhood cancer.
What are the organization's capabilities for doing this?
Throughout the year, Beat Childhood Cancer hosts several fundraising events for childhood cancer research. We have recently brought four childhood cancer nonprofits together into a single entity, creating a national group of families focused on beating childhood cancer for every child, everywhere allowing them to survive and thrive.
We've built a team of research and clinical collaborators to ensure kids across the US and internationally to have access to these therapies, and created a consortium of over 50+ children's hospitals to do so, through the Beat Childhood Cancer Research Consortium.
What have they accomplished so far and what's next?
Since 2010 we have been able to direct over $8 million to doctors and researchers conducting patient-affecting research and clinical trials for neuroblastoma and other childhood cancers. Each year our fundraising and research goals continue to grow and we won't stop funding research until there is a cure for childhood cancer.
We are continuing to add more locations for our clinical trials to be operated in, and look for better treatment options. Ridding kids of cancer is only one part of saving them. We must also maintain fertility, cognitive capacity and organ function for another 7 decades of life. Every child deserves to survive and thrive.
Financials
Financial documents
Download audited financialsRevenue vs. expenses: breakdown
Liquidity in 2022 info
1.60
Months of cash in 2022 info
14.5
Fringe rate in 2022 info
7%
Funding sources info
Assets & liabilities info
Financial data
Beat Childhood Cancer Foundation Inc
Revenue & expensesFiscal Year: Jan 01 - Dec 31
Beat Childhood Cancer Foundation Inc
Balance sheetFiscal Year: Jan 01 - Dec 31
The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.
Fiscal Year: Jan 01 - Dec 31
This snapshot of Beat Childhood Cancer Foundation Inc’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.
Created in partnership with
Business model indicators
Profitability info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Unrestricted surplus (deficit) before depreciation | -$76,624 | $97,106 | $467,542 | -$211,391 | $248,759 |
As % of expenses | -6.4% | 6.2% | 33.0% | -11.1% | 15.0% |
Unrestricted surplus (deficit) after depreciation | -$76,624 | $97,106 | $466,592 | -$213,291 | $246,859 |
As % of expenses | -6.4% | 6.2% | 32.9% | -11.2% | 14.9% |
Revenue composition info | |||||
---|---|---|---|---|---|
Total revenue (unrestricted & restricted) | $1,118,299 | $1,652,218 | $2,162,103 | $1,628,336 | $4,488,841 |
Total revenue, % change over prior year | 7.2% | 47.7% | 30.9% | -24.7% | 175.7% |
Program services revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Membership dues | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Investment income | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Government grants | 0.0% | 0.0% | 1.3% | 0.0% | 0.0% |
All other grants and contributions | 100.0% | 100.0% | 98.7% | 100.0% | 100.0% |
Other revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Expense composition info | |||||
---|---|---|---|---|---|
Total expenses before depreciation | $1,194,923 | $1,555,112 | $1,418,471 | $1,907,325 | $1,659,765 |
Total expenses, % change over prior year | 23.4% | 30.1% | -8.8% | 34.5% | -13.0% |
Personnel | 11.0% | 9.8% | 16.8% | 10.4% | 14.2% |
Professional fees | 1.4% | 2.8% | 5.5% | 4.2% | 4.9% |
Occupancy | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% |
Interest | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Pass-through | 80.3% | 80.4% | 70.8% | 76.0% | 75.3% |
All other expenses | 7.2% | 6.9% | 6.9% | 9.4% | 5.6% |
Full cost components (estimated) info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Total expenses (after depreciation) | $1,194,923 | $1,555,112 | $1,419,421 | $1,909,225 | $1,661,665 |
One month of savings | $99,577 | $129,593 | $118,206 | $158,944 | $138,314 |
Debt principal payment | $0 | $0 | $0 | $0 | $0 |
Fixed asset additions | $0 | $0 | $9,500 | $0 | $0 |
Total full costs (estimated) | $1,294,500 | $1,684,705 | $1,547,127 | $2,068,169 | $1,799,979 |
Capital structure indicators
Liquidity info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Months of cash | 9.9 | 8.7 | 13.9 | 11.8 | 14.5 |
Months of cash and investments | 9.9 | 8.7 | 13.9 | 11.8 | 14.5 |
Months of estimated liquid unrestricted net assets | 0.3 | 1.0 | 4.9 | 2.3 | 4.5 |
Balance sheet composition info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Cash | $989,693 | $1,126,799 | $1,643,096 | $1,878,368 | $2,003,464 |
Investments | $0 | $0 | $0 | $0 | $0 |
Receivables | $0 | $250,000 | $200,000 | $65,000 | $2,656,999 |
Gross land, buildings, equipment (LBE) | $0 | $0 | $9,500 | $9,500 | $10,735 |
Accumulated depreciation (as a % of LBE) | 0.0% | 0.0% | 10.0% | 30.0% | 44.2% |
Liabilities (as a % of assets) | 97.2% | 90.9% | 53.7% | 69.9% | 26.8% |
Unrestricted net assets | $27,632 | $124,738 | $591,330 | $378,039 | $624,898 |
Temporarily restricted net assets | $0 | N/A | N/A | N/A | N/A |
Permanently restricted net assets | $0 | N/A | N/A | N/A | N/A |
Total restricted net assets | $0 | $0 | $276,090 | $208,492 | $2,788,809 |
Total net assets | $27,632 | $124,738 | $867,420 | $586,531 | $3,413,707 |
Key data checks
Key data checks info | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Material data errors | No | No | No | No | No |
Operations
The people, governance practices, and partners that make the organization tick.
Documents
Executive Director
Sarah Bartosz
Sarah serves as Executive Director of Beat Childhood Cancer. Her son Jack was 4 years old when he was diagnosed with stage 4 neuroblastoma in 2005, and battled cancer nearly 7 years, before finding his ultimate cure in Heaven in 2012. She started I Back Jack in 2006, later changing the name to Gold in September (G9) and continued to #growGold for kids over the years. In July of 2020, G9 became a part of Beat Childhood Cancer, and we are proud to continue this work together.
Founder
Patrick Lacey
Patrick's son Will started fighting neuroblastoma cancer at just 7 months old. Pat founded a nonprofit called Friends of Will to help discover, fund, and drive forward options to help Will beat cancer - and he did.
Friends of Will became Beat Nb, and in July of 2020 became known as Beat Childhood Cancer.
Today, Will is a college student playing hockey in Braintree, MA with his two younger sisters.
Number of employees
Source: IRS Form 990
Beat Childhood Cancer Foundation Inc
Officers, directors, trustees, and key employeesSOURCE: IRS Form 990
Compensation data
There are no highest paid employees recorded for this organization.
Beat Childhood Cancer Foundation Inc
Board of directorsas of 03/14/2024
Board of directors data
John Foley
Eric Caisse
Board leadership practices
GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.
-
Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes -
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes -
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes -
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes -
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes
Organizational demographics
Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.
Leadership
No data
The organization's co-leader identifies as:
No data
Race & ethnicity
No data
Gender identity
Transgender Identity
Sexual orientation
No data
Disability
No data
We do not display disability information for organizations with fewer than 15 staff.